Max Healthcare Institute Ltd Stock Falls to 52-Week Low of Rs.933.8

Stock Performance and Market Context

On 2 Feb 2026, Max Healthcare’s share price touched an intraday low of Rs.933.8, representing a 4.34% drop from the previous close. The stock underperformed its sector by 1.78% and reversed a two-day consecutive gain trend. It is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained downward momentum.

In contrast, the broader market showed resilience. The Sensex, after opening 167.26 points lower, recovered to close 0.21% higher at 80,889.46 points. Mega-cap stocks led this recovery, while the NIFTY FMCG index also hit a 52-week low today, indicating sector-specific pressures in certain areas of the market.

Over the past year, Max Healthcare’s stock has declined by 15.45%, significantly underperforming the Sensex, which gained 4.43% during the same period. This divergence highlights challenges specific to the company and its sector, despite the overall market’s positive trajectory.

Valuation and Financial Metrics

Max Healthcare’s current valuation metrics contribute to its market performance. The company holds a Mojo Score of 43.0 and a Mojo Grade of Sell, downgraded from Hold on 31 Oct 2025. Its market capitalisation stands at approximately Rs.94,795 crore, making it the second largest hospital sector company after Apollo Hospitals and accounting for 18.18% of the sector’s market cap.

The stock’s return on capital employed (ROCE) is 13.2%, while the enterprise value to capital employed ratio is 7.6, indicating a relatively expensive valuation compared to historical peer averages. The price-to-earnings-to-growth (PEG) ratio is 2, reflecting moderate growth expectations priced into the stock.

Despite the negative stock price movement, the company’s profitability has improved. Over the past year, profits have increased by 33.5%, and the latest six-month period ending September 2025 showed a profit after tax (PAT) of Rs.799.27 crore, up 54.28%. Net sales for the same period rose 28.08% to Rs.4,163.04 crore, with quarterly PBDIT reaching a high of Rs.575.15 crore.

Operational and Sectoral Considerations

Max Healthcare operates in the hospital industry, a sector characterised by steady long-term growth. The company’s net sales have grown at an annual rate of 41.05%, while operating profit has surged by 312.75% over recent years. Its low average debt-to-equity ratio of 0.08 times underscores a conservative capital structure, which may provide some stability amid market fluctuations.

Institutional investors hold a significant 71.76% stake in the company, indicating confidence from entities with extensive analytical resources. However, the stock’s recent underperformance relative to the BSE500 index, which gained 4.23% over the last year, suggests that market sentiment has been cautious.

Technical and Market Dynamics

The stock’s decline to its 52-week low is compounded by its position below all major moving averages, which often signals bearish momentum in technical analysis. The 52-week high for Max Healthcare was Rs.1,314.3, indicating a substantial retracement of nearly 29% from that peak.

While the Sensex is trading below its 50-day moving average, the 50-day average remains above the 200-day average, suggesting that the broader market retains an overall upward trend despite short-term volatility. Max Healthcare’s relative underperformance within this context highlights sector-specific or company-specific factors influencing investor sentiment.

Given the company’s sizeable market capitalisation and significant share of the hospital sector’s sales—Rs.7,941.09 crore annually, representing 9.77% of the industry—the stock’s price movements are closely watched as an indicator of sector health.

Summary of Key Data Points

• New 52-week low: Rs.933.8 (intraday low on 2 Feb 2026)
• Day’s decline: -4.34% intraday, -3.34% day change
• 1-year stock return: -15.45%
• Sensex 1-year return: +4.43%
• ROCE: 13.2%
• Enterprise value to capital employed: 7.6
• PEG ratio: 2
• Debt to equity ratio: 0.08 times
• Institutional holdings: 71.76%
• Market cap: Rs.94,795 crore
• Annual sales: Rs.7,941.09 crore
• Latest six-month PAT growth: 54.28%
• Latest six-month net sales growth: 28.08%

These figures illustrate a complex picture where strong financial growth contrasts with a declining share price, reflecting valuation concerns and market dynamics within the hospital sector.

Conclusion

Max Healthcare Institute Ltd’s fall to a 52-week low of Rs.933.8 underscores the challenges faced by the stock amid broader market fluctuations and sector-specific pressures. Despite robust profit growth and a solid balance sheet, the stock’s valuation metrics and technical indicators have weighed on its price performance. The divergence between the company’s financial results and its share price highlights the nuanced environment investors are navigating in the hospital sector.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →